Difference between revisions of "Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5 (Q9886)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Biomed. Res. Int., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): 2820853-, #quickstatements; #temporary_batch_1590074839150) |
||
(2 intermediate revisions by the same user not shown) | |||
Property / Volume | |||
+ | 2019 | ||
Property / Volume: 2019 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | Mesenchymal stem cells and cancer: clinical challenges and opportunities (English) | ||
Property / title: Mesenchymal stem cells and cancer: clinical challenges and opportunities (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 2820853- | ||
Property / Page(s): 2820853- / rank | |||
+ | Normal rank |
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Lin W
0 references
2019
0 references
Biomed. Res. Int.
0 references
2019
0 references
Mesenchymal stem cells and cancer: clinical challenges and opportunities (English)
0 references
2820853-
0 references